An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Philip Morris International Inc. to Publish a Video Presentation at the 2022 Consumer Analyst Group of New York (CAGNY) Virtual Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Philip Morris International (NYSE: PM) will release a pre-recorded business presentation by CEO Jacek Olczak and CFO Emmanuel Babeau at the Consumer Analyst Group of New York (CAGNY) virtual conference. The video will be available from February 23, 2022, at 9:10 a.m. ET until March 24, 2022. PMI is committed to a smoke-free future, having invested over USD 9 billion since 2008 to develop smoke-free products, which are available in 71 markets. Approximately 15.3 million adults have switched to PMI's IQOS products to date.
Positive
Invested over USD 9 billion since 2008 in smoke-free product development.
PMI's smoke-free products available in 71 markets.
15.3 million adults have switched to IQOS products.
Negative
None.
NEW YORK--(BUSINESS WIRE)--
Regulatory News:
Philip Morris International Inc. (NYSE: PM) will publish a pre-recorded video of a business presentation by Jacek Olczak, Chief Executive Officer, and Emmanuel Babeau, Chief Financial Officer, at the Consumer Analyst Group of New York (CAGNY) virtual conference.
The video can be accessed at www.pmi.com/2022cagny on Wednesday, February 23, 2022, as of approximately 9:10 a.m. ET. The video will remain available on the same site until 5:00 p.m. ET on Thursday, March 24, 2022.
The video may also be accessed on iOS or Android devices by downloading PMI’s free Investor Relations Mobile Application at www.pmi.com/irapp.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the U.S. Since 2008, PMI has invested more than USD 9 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. The U.S. Food and Drug Administration (FDA) has authorized the marketing of a version of PMI’s IQOS Platform 1 device and consumables as a Modified Risk Tobacco Product (MRTP), finding that an exposure modification order for these products is appropriate to promote the public health. As of December 31, 2021, PMI's smoke-free products are available for sale in 71 markets, and PMI estimates that approximately 15.3 million adults around the world have already switched to IQOS and stopped smoking. With a strong foundation and significant expertise in life-sciences, in February 2021 PMI announced its ambition to expand into wellness and healthcare areas and deliver innovative products and solutions that aim to address unmet patient and consumer needs. For more information, please visit www.pmi.com and www.pmiscience.com.
